Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PFIZER Latest News

JUL 14, 2014 - Yahoo! News

A Must Read - Share

Targacept ends Alzheimer's drug trial after mid-stage failure

(Reuters) - Targacept Inc said it was ending a mid-stage trial on its Alzheimer's drug as it did not show superiority over standard medication, sending its shares down as much as 19.8 percent. The drug, TC-1734, which was being tested against Pfizer Inc's donepezil, had earlier failed another mid-stage trial conducted by partner AstraZeneca Plc. "Based on (today's) results, we ...

Tags: Targacept ends Alzheimer's drug trial after mid-stage failure,  Pfizer Latest News

JUL 14, 2014 - Yahoo! News

A Must Read - Share

Targacept stops Alzheimer's drug trial after it fails mid-stage

(Reuters) - Targacept Inc said its experimental Alzheimer's drug did not show superiority over standard medication in a mid-stage study and that it would no longer invest in the development of the treatment. The company's shares were down about 16.44 percent. The drug, TC-1734, was being tested against Pfizer Inc's donepezil. (Reporting By Amrutha Penumudi; Editing by Don Sebastian)

Tags: Targacept stops Alzheimer's drug trial after it fails mid-stage,  Pfizer Latest News

JUL 14, 2014 - Yahoo! News

A Must Read - Share

Shire ready to bow to AbbVie's increased $53 billion offer

By Kate Holton LONDON (Reuters) - London-listed drugmaker Shire Plc succumbed to an increased 31 billion pounds ($53 billion) takeover offer from Abbvie Inc on Monday, signaling the conclusion to a long-running courtship largely motivated by tax. Shire said it was ready to recommend the deal, the latest in a list of mergers proposed by U.S. firms seeking to cut ...

Tags: Shire ready to bow to AbbVie's increased $53 billion offer,  Pfizer Latest News

JUL 08, 2014 - Yahoo! News

A Must Read - Share

Pfizer wins dismissal of U.S. investor class action ahead of trial

By Nate Raymond NEW YORK (Reuters) - Pfizer Inc won the dismissal Tuesday of a long-running shareholder class action accusing the company of misleading investors about the safety of its Celebrex and Bextra pain-relieving drugs. The ruling by U.S. District Judge Laura Taylor Swain in New York came ahead of a Sept. 9 trial in the case, which investors launched ...

Tags: Pfizer wins dismissal of U.S. investor class action ahead of trial,  Pfizer Latest News